ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 49 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $643,000 | -74.3% | 667,800 | -27.2% | 0.08% | -61.4% |
| Q4 2019 | $2,506,000 | -5.6% | 917,800 | +36.2% | 0.21% | -49.5% |
| Q3 2019 | $2,655,000 | +32.8% | 673,881 | +37.2% | 0.41% | +50.2% |
| Q2 2019 | $1,999,000 | -34.0% | 491,193 | +13.9% | 0.27% | -1.1% |
| Q1 2019 | $3,027,000 | +60.9% | 431,193 | +24.9% | 0.28% | +30.2% |
| Q4 2018 | $1,881,000 | -40.7% | 345,199 | +16.9% | 0.21% | -41.8% |
| Q3 2018 | $3,170,000 | -9.0% | 295,199 | +10.4% | 0.36% | -24.2% |
| Q2 2018 | $3,484,000 | -22.9% | 267,349 | -34.8% | 0.48% | -30.0% |
| Q1 2018 | $4,520,000 | +38.2% | 410,199 | +26.2% | 0.69% | +78.6% |
| Q4 2017 | $3,270,000 | – | 325,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $15,889,000 | 50.04% |
| TRV GP II, LLC | 2,790,964 | $19,593,000 | 12.78% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $23,379,000 | 5.63% |
| Partner Investment Management, L.P. | 296,961 | $2,085,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 431,193 | $3,027,000 | 0.28% |
| PFM Health Sciences, LP | 1,463,208 | $10,272,000 | 0.23% |
| Perceptive Advisors | 132,300 | $929,000 | 0.03% |
| Fosun International Ltd | 29,877 | $209,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $584,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 343,574 | $2,412,000 | 0.01% |